CDXS stock forecast
Our latest prediction for Codexis, Inc.'s stock price was made on the Aug. 20, 2019 when the stock price was at 13.01$.
In the short term (2weeks), CDXS's stock price should outperform the market by 3.75%. During that period the price should oscillate between -6.12% and +10.91%.
In the medium term (3months), CDXS's stock price should outperform the market by 4.99%. During that period the price should oscillate between -15.51% and +26.43%.Get email alerts
About Codexis, Inc.
Codexis, Inc. engages in the discovery, development, and sale of proteins. The company offers enzyme optimization services and developing biocatalyst products. The firm operates through the following segments: Performance Enzymes and Novel Biotherapeutics. Its technologies accelerate the development of manufacturing processes for active pharmaceutical ingredients fine chemicals, agrochemicals, food ingredients, detergents and biofuels. The company was founded in January 2002 and is headquartered in Redwood City, CA.
At the moment the company generates 61M USD in revenues.
On its last earning announcement, the company reported a loss of -0.25$ per share.
The book value per share is 0.98$
Three months stock forecastAug. 20, 2019
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|